You just read:

Enteris BioPharma Announces Completion of Recruitment in Expanded Phase 2a Clinical Trial of Ovarest® (oral leuprolide tablet) for Endometriosis

News provided by

Enteris BioPharma, Inc.

Apr 30, 2018, 08:02 ET